Location: Adrenal gland, near the kidney
Behaviour: Mostly benign
Diagnostics: Urine or blood test and imaging (ultrasonography, CT or MRI)
Treatment: Surgery, drugs that inhibit effect of adrenaline and drugs that affect tumour growth
Prognosis: Depends on the tumour size and hormone secretion
There are no pictures available for this tumour type
  1. Barthez PY, Marks SL, Woo J, Feldman EC, Matteucci M. Pheochromocytoma in dogs: 61 cases (1984-1995). J Vet Intern Med. 1997 Sep-Oct;11(5):272-8.
  2. ​Galac, S.; Korpershoek, E. Pheochromocytomas and paragangliomas in humans and dogs. Vet. Comp. Oncol. 2017, 15, 1158–1170.
  3. Herrera MA, Mehl ML, Kass PH, Pascoe PJ, Feldman EC, Nelson RW. Predictive factors and the effect of phenoxybenzamine on outcome in dogs undergoing adrenalectomy for pheochromocytoma. J Vet Intern Med. 2008 Nov-Dec;22(6):1333-9.
  4. Musser ML, Taikowski KL, Johannes CM, Bergman PJ. Retrospective evaluation of toceranib phosphate (Palladia®) use in the treatment of inoperable, metastatic, or recurrent canine pheochromocytomas: 5 dogs (2014-2017). BMC Vet Res. 2018 Sep 3;14(1):272.
  5. Zini E, Nolli S, Ferri F, Massari F, Gerardi G, Nicoli S, Romanelli G, Montinaro V, Trez D, Cavicchioli L, Ferro S. Pheochromocytoma in Dogs Undergoing Adrenalectomy. Vet Pathol. 2019 May;56(3):358-368.
Clinical trials

Centre Hospitalier Vétérinaire Frégis
Arcueil, France
+33 1 49 85 83 00